JPH03280839A - Feed additive for ruminant - Google Patents
Feed additive for ruminantInfo
- Publication number
- JPH03280839A JPH03280839A JP2080807A JP8080790A JPH03280839A JP H03280839 A JPH03280839 A JP H03280839A JP 2080807 A JP2080807 A JP 2080807A JP 8080790 A JP8080790 A JP 8080790A JP H03280839 A JPH03280839 A JP H03280839A
- Authority
- JP
- Japan
- Prior art keywords
- biologically active
- feed additive
- coating film
- fatty acid
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000282849 Ruminantia Species 0.000 title claims description 39
- 239000003674 animal food additive Substances 0.000 title claims description 24
- 230000001681 protective effect Effects 0.000 claims abstract description 35
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 30
- 239000000194 fatty acid Substances 0.000 claims abstract description 30
- 229930195729 fatty acid Natural products 0.000 claims abstract description 30
- 239000008187 granular material Substances 0.000 claims abstract description 28
- 239000000126 substance Substances 0.000 claims abstract description 23
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 22
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims abstract description 22
- -1 fatty acid salt Chemical class 0.000 claims abstract description 18
- 239000003921 oil Substances 0.000 claims abstract description 17
- 229940088623 biologically active substance Drugs 0.000 claims abstract description 16
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 14
- 239000003925 fat Substances 0.000 claims abstract description 11
- 230000007935 neutral effect Effects 0.000 claims abstract description 11
- 159000000007 calcium salts Chemical class 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 10
- 230000002378 acidificating effect Effects 0.000 claims abstract description 9
- 238000002844 melting Methods 0.000 claims abstract description 9
- 230000008018 melting Effects 0.000 claims abstract description 9
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims abstract description 5
- 229930182817 methionine Natural products 0.000 claims abstract description 5
- 229940088594 vitamin Drugs 0.000 claims abstract description 4
- 229930003231 vitamin Natural products 0.000 claims abstract description 4
- 235000013343 vitamin Nutrition 0.000 claims abstract description 4
- 239000011782 vitamin Substances 0.000 claims abstract description 4
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 claims abstract description 3
- 239000001913 cellulose Substances 0.000 claims abstract description 3
- 229920002678 cellulose Polymers 0.000 claims abstract description 3
- 229960005337 lysine hydrochloride Drugs 0.000 claims abstract description 3
- 229960004452 methionine Drugs 0.000 claims abstract 2
- 239000013543 active substance Substances 0.000 claims description 30
- 239000001993 wax Substances 0.000 claims description 8
- 229920003169 water-soluble polymer Polymers 0.000 claims 2
- 241000894007 species Species 0.000 claims 1
- 239000011248 coating agent Substances 0.000 abstract description 26
- 238000000576 coating method Methods 0.000 abstract description 26
- 210000004767 rumen Anatomy 0.000 abstract description 11
- 210000003165 abomasum Anatomy 0.000 abstract description 10
- 210000004798 organs belonging to the digestive system Anatomy 0.000 abstract description 8
- 150000003839 salts Chemical class 0.000 abstract description 6
- 239000000654 additive Substances 0.000 abstract description 3
- 210000004051 gastric juice Anatomy 0.000 abstract description 2
- 230000002633 protecting effect Effects 0.000 abstract 4
- 229960005196 titanium dioxide Drugs 0.000 abstract 3
- 230000000996 additive effect Effects 0.000 abstract 2
- 239000010408 film Substances 0.000 description 31
- 238000002360 preparation method Methods 0.000 description 16
- 235000019198 oils Nutrition 0.000 description 15
- 239000012530 fluid Substances 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- 235000019197 fats Nutrition 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- 239000007983 Tris buffer Substances 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 239000011253 protective coating Substances 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 235000014593 oils and fats Nutrition 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 229960003646 lysine Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000022676 rumination Effects 0.000 description 2
- 208000015212 rumination disease Diseases 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 239000000273 veterinary drug Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- WUNWNURVJGOTHZ-YFKPBYRVSA-N (2s)-2-(hydroxymethylamino)-4-methylsulfanylbutanoic acid Chemical class CSCC[C@@H](C(O)=O)NCO WUNWNURVJGOTHZ-YFKPBYRVSA-N 0.000 description 1
- NOMBOSYULRDSOO-YRBAHSOBSA-N (2s)-4-methylsulfanyl-2-[[(z)-octadec-9-enyl]amino]butanoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCN[C@H](C(O)=O)CCSC NOMBOSYULRDSOO-YRBAHSOBSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- AITZHKQVQNLKHI-UHFFFAOYSA-N 2-(4-(aminomethyl)piperidin-1-yl)-n-(3_cyclohexyl-4-oxo-2,4-dihydroindeno[1,2-c]pyrazol-5-yl)acetamide Chemical compound C1CC(CN)CCN1CC(=O)NC1=CC=CC2=C1C(=O)C1=C(C3CCCCC3)NN=C12 AITZHKQVQNLKHI-UHFFFAOYSA-N 0.000 description 1
- IWLYFBGNNDXONS-UHFFFAOYSA-N 2-hydroxy-2-sulfanylpentanoic acid Chemical group CCCC(O)(S)C(O)=O IWLYFBGNNDXONS-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 229940124339 anthelmintic agent Drugs 0.000 description 1
- 239000000921 anthelmintic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000007922 dissolution test Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- IZXGZAJMDLJLMF-UHFFFAOYSA-N methylaminomethanol Chemical compound CNCO IZXGZAJMDLJLMF-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000002763 monocarboxylic acids Chemical class 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000005453 pelletization Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、反芻動物用飼料添加剤に係り、さらに詳しく
は、反芻動物の第1胃の胃液から生物学的活性物質を保
護し、第4胃以降の消化器官において効率良く吸収させ
るべく、生物学的活性物質を脂肪酸塩の保護皮膜で被覆
した製剤に関する。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a feed additive for ruminants, and more particularly, it protects biologically active substances from the gastric juice of the rumen of ruminants. The present invention relates to a preparation in which a biologically active substance is coated with a protective coating of a fatty acid salt in order to be efficiently absorbed in the digestive organs starting from the four stomachs.
本発明の反芻動物用飼料添加剤は、飼料に添加混合し、
牛、羊等の反芻動物に経口投与することができ、アミノ
酸、タンパク質、動物医薬等の生物学的活性物質を効率
よく吸収させるための製剤として好適に使用される。The feed additive for ruminants of the present invention is added to feed and mixed,
It can be orally administered to ruminants such as cattle and sheep, and is suitably used as a preparation for efficiently absorbing biologically active substances such as amino acids, proteins, and veterinary drugs.
アミノ酸、タンパク質、動物医薬等の生物学的活性物質
を反芻動物に経口投与した場合、反芻動物の第1胃の胃
液に存在する微生物により分解され、そのまま吸収され
ることはない。When biologically active substances such as amino acids, proteins, and veterinary drugs are orally administered to ruminants, they are decomposed by microorganisms present in the gastric fluid of the rumen of the ruminant, and are not absorbed as is.
したがって、これらの生物学的活性物質を効率よく吸収
させることを目的として、生物学的活性物質を油脂等の
第1胃胃液に対して安定な物質で被覆保護し、第4胃以
降の消化器官で生物学的活性物質を放出させる反芻動物
用飼料添加剤が種々提案されており(特開昭56−15
4956号公報、特開昭61−151133号公報等参
照)、本発明の出願人も生物学的活性物質を、硬化油等
の保護物質にその保護物質の第4胃以降の消化器官にお
ける崩壊性を助長する目的でキトサンを加えて保護した
製剤を提案しく特開昭58−175449号公報、特開
昭59−198946号公報等参照)、ラフチット[F
]の名称で上布している。Therefore, in order to efficiently absorb these biologically active substances, the biologically active substances are coated and protected with a substance that is stable against the ruminal fluid, such as oil, and the digestive organs from the abomasum onward are protected. Various feed additives for ruminants that release biologically active substances have been proposed (Japanese Unexamined Patent Publication No. 56-15).
4956, Japanese Unexamined Patent Publication No. 151133/1983, etc.), the applicant of the present invention also added a biologically active substance to a protective substance such as hydrogenated oil, and determined the disintegrability of the protective substance in the digestive organs from the abomasum onwards. We propose a formulation protected by adding chitosan for the purpose of promoting
] It is published under the name.
一方、反芻動物の第1胃をバイパスし、第4胃以降の消
化器官において高効率で吸収されるエネルギー源として
、炭素数14.1Gおよび/または18の脂肪酸のカル
シウム、マグネシウム等の2価金属塩が提案され(US
P 4,826,694明細書参照)、天然油脂から製
造された混合脂肪酸のカルシウム塩(以下「バイパス油
脂」と称す)が市販されている。On the other hand, divalent metals such as calcium and magnesium of fatty acids with 14.1G and/or 18 carbon atoms are used as an energy source that bypasses the rumen of ruminants and is absorbed with high efficiency in the digestive organs after the abomasum. Salt was proposed (US
P 4,826,694), calcium salts of mixed fatty acids made from natural fats and oils (hereinafter referred to as "bypass fats") are commercially available.
またこれらのバイパス油脂をその融点以上の温度に加熱
して軟化し、その中に生物学的活性物質を添加混合した
後、冷却固化して粉砕する反芻動物用飼料添加剤の製造
法が知られている(特開昭63−313546号公報参
照)。In addition, there is a known method for producing feed additives for ruminants, in which these bypass fats and oils are heated to a temperature above their melting point to soften them, a biologically active substance is added and mixed therein, and then the mixture is cooled, solidified, and crushed. (Refer to Japanese Patent Laid-Open No. 63-313546).
前記引用した硬化油等の保護物質で生物学的活性物質を
被覆保護した反芻動物用飼料添加剤においては、生物学
的活性物質の第1胃バイパス性および第4胃以降の消化
器官での放出性に優れているか、貯蔵安定性、特に40
℃以上で保存した場合の熱安定性を改良することが要求
されている。In feed additives for ruminants in which biologically active substances are coated and protected with the above-mentioned protective substances such as hydrogenated oil, the biologically active substances have ruminal bypass properties and are released in the digestive tract from the abomasum onwards. Excellent properties and storage stability, especially 40%
There is a need for improved thermal stability when stored at temperatures above °C.
一方、バイパス油脂は、硬化油等に比較して融点が高く
、熱安定性に優れている。したがって、生物学的活性物
質をバイパス油脂で被覆保護した製剤は、熱安定性に優
れることが期待できるか、前記引用文献に記載の加熱軟
化したバイパス油脂に単に生物学的活性物質を混合する
方法で製造した製剤においては、種々の要因が重なり生
物学的活性物質の第1胃バイパス性が劣り、特に生物学
的活性物質を高含有させた製剤や、水溶性の高い生物学
的活性物質を含有する製剤においては、バイパス油脂の
保護皮膜による生物学的活性物質の十分な被覆が困難で
あることから、生物学的活性物質の第1胃バイパス性が
ほとんど発現せず、またバイパス油脂を構成する不飽和
脂肪酸が、空気中の酸素や光に対して不安定なことから
、保存安定性に欠けている。On the other hand, bypass oils and fats have a higher melting point and excellent thermal stability than hardened oils and the like. Therefore, it is expected that a preparation in which a biologically active substance is coated and protected with a bypass oil or fat has excellent thermal stability. Due to a combination of various factors, the ruminal bypass properties of biologically active substances are poor in preparations manufactured with 2-50% fluoride, especially in preparations containing high amounts of biologically active substances or those containing highly water-soluble biologically active substances. In preparations containing the bypass oil, it is difficult to sufficiently cover the biologically active substance with the protective film of the bypass oil, so the biologically active substance hardly exhibits ruminal bypass properties, and Because the unsaturated fatty acids that make up these ingredients are unstable to oxygen and light in the air, they lack storage stability.
本発明は、生物学的活性物質の第1胃バイパス性に優れ
たバイパス油脂を保護物質とする反芻動物用飼料添加剤
を提供することを、その目的とする。An object of the present invention is to provide a feed additive for ruminants that uses as a protective substance a bypass oil and fat that has excellent ruminal bypass properties for biologically active substances.
本発明者等は、前記目的を達成すべく鋭意研究した結果
、生物学的活性物質を含有する核顆粒を脂肪酸塩と油脂
、ワックス等とからなる保護皮膜で被覆することにより
、生物学的活性物質の第1胃バイパス性が著しく向上す
ること、およびさらに前記被覆製剤を酸化チタン含有皮
膜で被覆することにより保存安定性が著しく向上するこ
とを見出し、本発明を完成した。As a result of intensive research to achieve the above object, the present inventors have discovered that biologically active substances can be activated by coating core granules containing biologically active substances with a protective film made of fatty acid salts, oils, fats, waxes, etc. The inventors have completed the present invention by discovering that the rumen bypass properties of the substance are significantly improved, and that the storage stability is significantly improved by coating the coated preparation with a titanium oxide-containing film.
本発明は、生物学的活性物質と保護物質とを含有する核
顆粒を、(a)中性域では不溶性であり酸性域では分解
性を示す脂肪酸塩と、(b)油脂およびワックスよりな
る群から選ばれた少な(とも1種とからなる保護皮膜と
酸化チタン含有皮膜とで二層被覆したことを特徴とする
反芻動物用飼料添加剤である。The present invention provides core granules containing a biologically active substance and a protective substance, comprising (a) a fatty acid salt that is insoluble in a neutral range and decomposable in an acidic range, and (b) a group consisting of oils, fats, and waxes. This feed additive for ruminants is characterized by being coated with two layers: a protective film consisting of one type selected from the following, and a titanium oxide-containing film.
本発明において、生物学的活性物質は、動物に供与して
肥育促進、疾病予防、疾病治療等の活性を示す物質であ
り、特に反衝動物に経口投与した場合、第1胃において
第1胃内に存在する微生物により分解され、そのままで
は効力が発現されにくい物質である。In the present invention, the biologically active substance is a substance that is given to animals and exhibits activities such as promoting fattening, preventing diseases, and treating diseases. It is a substance that is decomposed by the microorganisms present in the body, and is difficult to exert its effects as it is.
たとえばアミノ酸類:メチオニン、リジン、トリプトフ
ァン等、N−アシルアミノ酸類二N−ステアロイルメチ
オニン、N−オレイルメチオニン。For example, amino acids: methionine, lysine, tryptophan, etc., N-acyl amino acids diN-stearoylmethionine, N-oleylmethionine.
N−ヒドロキシメチルメチオニンのカルシウム塩等、ア
ミノ酸の塩類:リジン塩酸塩等、アミノ酸のヒドロキシ
同族化合物類=2−ヒドロキシ−4−メチルメルカプト
酪酸およびそのカルシウム塩等、タンパク質類:無粉末
、カゼイン、馬鈴薯蛋白、大豆蛋白等、ビタミン類:ビ
タミンA、ビタミンA酢酸エステル、ビタミンAパルミ
チン酸エステル塩、ビタミンD31 ビタミンE、ニ
コチン酸およびニコチン酸アミド、パントテン酸カルシ
ウム、β−カロチン等、酵素類;酸性プロテアーゼ等、
炭水化物類:ぶどう糖等、獣医薬類:ペニシリン、テト
ラサイクリン等の抗生物質、ネグフォン等の駆虫薬等が
挙げられ、それらの1種または2種以上が使用される。Salts of amino acids, such as calcium salts of N-hydroxymethylmethionine: Hydroxy homologues of amino acids, such as lysine hydrochloride = 2-hydroxy-4-methylmercaptobutyric acid and its calcium salts, etc., Proteins: Powder-free, casein, potato Protein, soy protein, etc., vitamins: vitamin A, vitamin A acetate, vitamin A palmitate, vitamin D31, vitamin E, nicotinic acid and nicotinamide, calcium pantothenate, β-carotene, etc., enzymes: acidic protease etc,
Carbohydrates: glucose, etc. Veterinary medicines: antibiotics such as penicillin and tetracycline, anthelmintics such as Negfon, etc., and one or more of these are used.
核顆粒の成分である保護物質は、pH5〜8の中性域に
ある反芻動物の第1胃胃液に安定で、pH3以下の強酸
性域の第4胃胃液または第4胃以降の消化器官の消化液
で分解するものであればよい。The protective substance, which is a component of the nuclear granule, is stable in the ruminal fluid of ruminants, which has a neutral pH of 5 to 8, and is stable in the ruminal fluid of ruminants, which has a neutral pH of 5 to 8, and is stable in the ruminal fluid of ruminants, which has a neutral pH of 5 to 8. Any material that can be broken down by digestive juices is fine.
たとえば炭素数8〜22の直鎖または分枝を有する飽和
または不飽和のモノカルボン酸およびその塩、硬化した
動植物油等が挙げられ、それらの1種または2種以上が
使用される。好ましくは炭素数14〜18の直鎖または
分枝を有する飽和または不飽和の脂肪酸の2価金属塩を
、さらに好ましくはそれらのカルシウム塩を使用する。For example, linear or branched saturated or unsaturated monocarboxylic acids having 8 to 22 carbon atoms and their salts, hardened animal and vegetable oils, etc. may be mentioned, and one or more of these may be used. Preferably, divalent metal salts of linear or branched saturated or unsaturated fatty acids having 14 to 18 carbon atoms are used, and more preferably their calcium salts are used.
核顆粒の成分として、前記生物学的活性物質および保護
物質以外に、炭酸カルシウム、炭酸マグネシウム、リン
酸カルシウム等の無機粉末を、所望により比重調節剤と
して添加することができる。As a component of the core granule, in addition to the biologically active substance and protective substance, inorganic powders such as calcium carbonate, magnesium carbonate, calcium phosphate, etc. can be added as a specific gravity regulator, if desired.
核顆粒は、前記生物学的活性物質の1種または2種以上
および所望により添加される比重調節剤を、保護物質を
バインダーとして顆粒化したものであり、通常、各成分
を均一に混合した後、加熱軟しペレット化して冷却固化
することにより製造される。Core granules are made by granulating one or more of the above-mentioned biologically active substances and a specific gravity regulator added if desired, using a protective substance as a binder, and are usually prepared after uniformly mixing each component. It is manufactured by heating, softening, pelletizing, cooling and solidifying.
粒状化法として、押出造粒法、攪拌造粒法等、−船釣な
造粒法を採用することができる。As the granulation method, a conventional granulation method such as an extrusion granulation method or an agitation granulation method can be employed.
好ましくは、押出造粒法により軟化状態の前記混合物を
紐状に押し出し、ホットカットして粒状化する。顆粒の
形状として、球状、楕円状等より真球に近いものが好ま
しい。Preferably, the softened mixture is extruded into strings by extrusion granulation, and then hot-cut to granulate. The shape of the granules is preferably closer to a true sphere than spherical, elliptical, etc.
保護皮膜に使用する中性域では不溶性であり、酸性域で
は分解性を示す脂肪酸塩は、前記保護物質と同様に反芻
動物の第1胃胃液に安定で第4胃胃液で分解する脂肪酸
の塩、たとえば前記引用した炭素数14.16および/
または18の脂肪酸のカルシウム塩、天然油脂から製造
される混合脂肪酸のカルシウム塩等が使用される。The fatty acid salt used for the protective film is insoluble in a neutral range and degradable in an acidic range, and is a salt of a fatty acid that is stable in the ruminal juice of a ruminant and decomposed in the abomasal juice, similar to the above-mentioned protective substance. , for example, the carbon number 14.16 cited above and /
Alternatively, calcium salts of 18 fatty acids, calcium salts of mixed fatty acids produced from natural oils and fats, etc. are used.
好ましくは融点が30〜50℃、さらに好ましくは35
〜45℃の混合脂肪酸のカルシウム塩が使用される。Preferably the melting point is 30 to 50°C, more preferably 35°C.
Calcium salts of mixed fatty acids at ~45°C are used.
また保護皮膜の一方の成分として、油脂、すなわち前記
脂肪酸類のトリグリセライド、糠ワックス等のワックス
類などが使用される。特に融点が55〜80℃の範囲に
あるトリグリセライドが好ましく使用される。Also, as one component of the protective film, oils and fats, ie, triglycerides of the aforementioned fatty acids, waxes such as bran wax, and the like are used. In particular, triglycerides having a melting point in the range of 55 to 80°C are preferably used.
保護皮膜は、コーティング機械を用い、溶融した前記ト
リグリセライド等に前記脂肪酸塩粉末を分散したスラリ
ーをコーテイング液として核顆粒にコーティングを行う
ことにより、容易に形成される。The protective film is easily formed by coating the core granules using a coating machine using a slurry in which the fatty acid salt powder is dispersed in the molten triglyceride or the like as a coating liquid.
酸化チタン含有皮膜は、皮膜形成性物質に、酸化チタン
の粉末を混合、含有させた皮膜である。A titanium oxide-containing film is a film in which titanium oxide powder is mixed and contained in a film-forming substance.
皮膜形成性物質として、たとえばヒドロキシプロピルセ
ルロース(以下rHPc」と称す)、ヒドロキシプロピ
ルメチルセルロース等の水溶性セルロース誘導体が好適
に用いられ、さらに柔軟性や−層目の保護皮膜との接着
性を付与することを目的として、ポリエチレングリコー
ル(以下rPEGjと称す)、グリセリン等が添加され
る。As the film-forming substance, water-soluble cellulose derivatives such as hydroxypropyl cellulose (hereinafter referred to as rHPc) and hydroxypropyl methylcellulose are preferably used, and further impart flexibility and adhesion to the protective film of the second layer. For this purpose, polyethylene glycol (hereinafter referred to as rPEGj), glycerin, etc. are added.
前記酸化チタン含有皮膜は、コーティング装置を用い、
皮膜形成性物質、酸化チタンの粉末等、PEG等の添加
物を水に溶解、分散したスラリーをコーテイング液とし
て、前記脂肪酸塩の保護皮膜で被覆した製剤にコーティ
ングすることにより形成される。The titanium oxide-containing film is formed using a coating device,
It is formed by using a slurry in which a film-forming substance, powder of titanium oxide, and additives such as PEG are dissolved and dispersed in water as a coating liquid, and coating the preparation coated with the protective film of the fatty acid salt.
保護皮膜および酸化チタン含有皮膜は通常のコーティン
グ装置を使用することにより形成され、例えば流動層式
、転勤式装置で行われる。この際使用する核顆粒は、コ
ーティング効率の点から丸みを有したものが好ましい。The protective coating and the titanium oxide-containing coating are formed using conventional coating equipment, such as a fluidized bed type or transfer type equipment. The core granules used at this time are preferably rounded from the viewpoint of coating efficiency.
本発明は、前記したように生物学的活性物質を含有する
核顆粒を、中性域では不溶性であり、酸性域では分解性
を示す脂肪酸塩と油脂、ワックス等とからなる保護皮膜
で被覆した上に、さらに酸化チタン含有皮膜を被覆した
ことを特徴とする反芻動物用飼料添加剤である。As described above, the present invention covers core granules containing biologically active substances with a protective film consisting of a fatty acid salt, oil, fat, wax, etc., which is insoluble in a neutral range and degradable in an acidic range. This feed additive for ruminants is further coated with a titanium oxide-containing film.
本発明において、保護皮膜の成分である脂肪酸塩が、中
性域では不溶性かつ酸性域では分解性であることから、
pH5〜8の範囲にある反芻動物の第1胃の胃液に極め
て安定であり、pH3以下の反芻動物の第4胃で容易に
分解する。その結果、核顆粒中に含まれる生物学的活性
物質が反芻動物の第4胃で溶出し、それ以降の消化器官
で効率よく吸収される。In the present invention, since the fatty acid salt that is a component of the protective film is insoluble in a neutral range and degradable in an acidic range,
It is extremely stable in the gastric fluid of the rumen of ruminants with a pH in the range of 5 to 8, and is easily degraded in the abomasum of ruminants with a pH of 3 or less. As a result, the biologically active substances contained in the nuclear granules are eluted in the abomasum of the ruminant and are efficiently absorbed in the subsequent digestive organs.
さらに核顆粒製造時のバインダーとして、それ自体中性
域で不溶性で酸性域で分解性の保護物質を用いることに
より、生物学的活性物質の第1胃バイパス性が向上する
。特に被覆物質と同種の脂肪酸カルシウムを採用するこ
とにより、核顆粒と皮膜との結合力が強化され、その結
果、反芻による製剤の破壊も減少し生物学的活性物質の
第1胃バイパス率がさらに向上する。Furthermore, by using a protective substance that is itself insoluble in a neutral range and decomposable in an acidic range as a binder during the production of core granules, the rumen bypass properties of biologically active substances are improved. In particular, by using the same type of fatty acid calcium as the coating material, the binding force between the core granules and the coating is strengthened, and as a result, the destruction of the preparation due to rumination is reduced, further increasing the ruminal bypass rate of biologically active substances. improves.
また保護皮膜の成分として油脂、ワックス等を用いるこ
とにより、脂肪酸塩のみで形成した皮膜に比較して膜質
が緻密となり、生物学的活性物質の第1胃における溶出
率が低下しバイパス率か向上する。その結果、核顆粒中
に含まれる生物学的活性物質が反芻動物の第4胃で溶出
し、それ以降の消化器官で効率よく吸収される。In addition, by using oils, waxes, etc. as components of the protective film, the film quality becomes denser than that of a film formed only with fatty acid salts, which reduces the elution rate of biologically active substances in the rumen and improves the bypass rate. do. As a result, the biologically active substances contained in the nuclear granules are eluted in the abomasum of the ruminant and are efficiently absorbed in the subsequent digestive organs.
また核顆粒に保護皮膜を形成する温度が、脂肪酸塩のみ
の保護皮膜を形成する場合の120〜130℃に比較し
て、脂肪酸、油脂、ワックス等の融点温度:60〜80
℃の低温であることから、生物学的活性物質の熱分解が
防止されるだけでなく、作業性も向上する。Furthermore, the temperature at which a protective film is formed on the core granules is 120 to 130°C when forming a protective film of only fatty acid salts, whereas the melting point temperature of fatty acids, oils, fats, waxes, etc. is 60 to 80°C.
The low temperature of ℃ not only prevents thermal decomposition of biologically active substances but also improves workability.
さらに核顆粒製造時のバインダーとして、それ自体中性
域で不溶性で酸性域で分解性の保護物質を用いることに
より、生物学的活性物質の第1胃バイパス性が向上する
。特に保護皮膜と同種の脂肪酸塩を採用することにより
、核顆粒と保護皮膜との結合力が強化され、その結果、
反芻による製剤の破壊も減少し生物学的活性物質の第1
胃バイパス率がさらに向上する。Furthermore, by using a protective substance that is itself insoluble in a neutral range and decomposable in an acidic range as a binder during the production of core granules, the rumen bypass properties of biologically active substances are improved. In particular, by using the same type of fatty acid salt as the protective coating, the bonding force between the core granules and the protective coating is strengthened, and as a result,
Destruction of the preparation due to rumination is also reduced and the first biologically active substance
Gastric bypass rates will further improve.
また外層の酸化チタン含有皮膜は、酸素を遮断し前記保
護皮膜な酸化を防止するだけでなく、含有する酸化チタ
ンが光を遮断することから、光による変質をも防止する
。その結果、貯蔵安定性が向上する。Furthermore, the titanium oxide-containing film of the outer layer not only blocks oxygen and prevents oxidation of the protective film, but also prevents deterioration due to light because the titanium oxide it contains blocks light. As a result, storage stability is improved.
本発明を、実施例および比較例によりさらに詳細に説明
する。The present invention will be explained in more detail by Examples and Comparative Examples.
たたし、本発明の範囲は、以下の実施例により何等の制
限を受けるものではない。However, the scope of the present invention is not limited in any way by the following examples.
なお、以下の鋼中において、「部」および「%」は、特
に断りのない限り重量基準である。In addition, in the following steel, "parts" and "%" are based on weight unless otherwise specified.
(1) 核顆粒の調製
融点43℃の牛脂脂肪酸のカルシウム塩を130〜14
0℃に加熱して溶融し、その中にメチオニン粉末または
りシン塩酸塩粉末を添加し約l。(1) Preparation of core granules Calcium salt of beef tallow fatty acid with a melting point of 43°C
Heat it to 0°C to melt it, and add about 1 liter of methionine powder or risine hydrochloride powder to it.
分間混練した後、室温まで冷却して粉砕、篩別し粒径0
.5〜3 m mの核顆粒+A−1−A、−4を調製し
た。After kneading for a minute, it was cooled to room temperature, crushed and sieved, and the particle size was 0.
.. Nuclear granules +A-1-A and -4 of 5 to 3 mm were prepared.
得られた核顆粒の組成および粒径を第1表中に示す。The composition and particle size of the obtained core granules are shown in Table 1.
(2)保護被膜による被覆製剤の調製
前記第(1)項で調製した核顆粒:A−1−A−4の核
1kgを、コーティング装置(ヘンシェルミキサー)に
仕込み、攪拌しながら65〜70℃に加熱した。この中
に前記第(1)項で用いたものと同一の脂肪酸カルシウ
ムの粉末および融点が60°Cの牛脂硬化油を添加しな
がら攪拌を続け、核顆粒の表面に保護皮膜を形成して被
覆し、反芻動物用飼料添加剤を調製した。(2) Preparation of coated preparation with protective film 1 kg of core granules A-1-A-4 prepared in the above item (1) was placed in a coating device (Henschel mixer) and heated to 65 to 70°C while stirring. heated to. Adding the same fatty acid calcium powder and hydrogenated beef tallow oil with a melting point of 60°C as used in item (1) above to this mixture, stirring is continued to form a protective film on the surface of the core granules to coat them. Then, a feed additive for ruminants was prepared.
得られた反芻動物用飼料添加剤の組成、被覆量および生
物学的活性物質の含有量を第1表中に示す。The composition, coating amount, and biologically active substance content of the obtained feed additive for ruminants are shown in Table 1.
(3)酸化チタン含有皮膜による被覆
コーティング機械(ハイコター、フロイント産業(株)
製)を用い、前記(2)項で調製した被覆製剤および第
(1)項で調製した核顆粒二A−2、A−4(比較用)
の各1kgに下記組成のコーテイング液を用いて酸化チ
タン含有皮膜を形成し、反芻動物用飼料添加剤を調製し
た。(3) Coating machine with titanium oxide-containing film (Hi-Coter, Freund Sangyo Co., Ltd.)
Coated preparation prepared in section (2) above and nuclear granules 2A-2 and A-4 prepared in section (1) (for comparison)
A titanium oxide-containing film was formed on 1 kg of each sample using a coating solution having the following composition to prepare a feed additive for ruminants.
〔コーテイング液組成〕 重量部酸化チタン
粉末 4.8ヒドロキシプロピルセ
ルロース 16.0(HPC:6曹HPC−8L)
ポリエチレングリコール 1.6(PEG:
マクロゴール6000)
水 84.
0得られた反芻動物用飼料添加剤の酸化チタン含有皮膜
の組成を第1表中に示す。[Coating liquid composition] Part by weight Titanium oxide powder 4.8 Hydroxypropyl cellulose 16.0 (HPC: 6 carbonate HPC-8L) Polyethylene glycol 1.6 (PEG:
Macrogol 6000) Water 84.
The composition of the titanium oxide-containing film of the obtained feed additive for ruminants is shown in Table 1.
(4)生物学的活性物質の溶出試験
前記第(3)項で調製した反芻動物用飼料添加剤および
比較のための前記第(1)項で調製した核顆粒の各2g
を、牛の第1胃胃液に対応するTris緩衝液200c
cに浸漬し、37℃の温度下に24時間振盪保持した後
、Tris緩衝液から取り出し牛の第4胃胃液に対応す
る0、05M(=m。(4) Dissolution test of biologically active substances 2 g each of the ruminant feed additive prepared in the above item (3) and the core granules prepared in the above item (1) for comparison
and Tris buffer 200c corresponding to bovine ruminal fluid.
After shaking and holding at a temperature of 37°C for 24 hours, it was taken out from the Tris buffer and 0.05M (=m) corresponding to bovine abomasal fluid.
A−dm−’)塩酸200ccに浸漬し、37°Cの温
度下にさらに4時間振盪した。ついで0.05 M塩酸
から取り出した製剤を、牛の小腸対応液200ccに浸
漬し、37°Cの温度下にさらに4時間振盪した。A-dm-') It was immersed in 200 cc of hydrochloric acid and further shaken at a temperature of 37°C for 4 hours. Then, the preparation taken out from the 0.05 M hydrochloric acid was immersed in 200 cc of a solution corresponding to bovine small intestine, and further shaken at a temperature of 37°C for 4 hours.
Tris緩衝液
Tris[ニドリス(ヒドロキシメチル)アミノメタン
]6.06gを、292mlの0.1 M塩酸に溶解し
、水で1000mlに希釈したpH8,0の溶液
ついで、Tris緩衝液、0.05 M塩酸および小腸
対応液に溶出したメチオニンおよびリジンを、ヨード滴
定法またはニンヒドリン発色法により定量した。ビタミ
ンEの定量は高速液体クロマトグラフィーにより行った
。Tris buffer 6.06 g of Tris [nidris(hydroxymethyl)aminomethane] was dissolved in 292 ml of 0.1 M hydrochloric acid, diluted to 1000 ml with water, pH 8.0, and then Tris buffer, 0.05 M Methionine and lysine eluted in hydrochloric acid and the corresponding small intestine fluid were quantified by iodine titration or ninhydrin color method. Quantification of vitamin E was performed by high performance liquid chromatography.
試験結果を、第1表中に示す。The test results are shown in Table 1.
(5)保存安定性試験
前記第(3)項で調製した反芻動物用飼料添加剤および
比較のための前記第(1)項で調製した核顆粒の各2g
を、直射日光下に80日間放置した。(5) Storage stability test 2 g each of the ruminant feed additive prepared in the above item (3) and the core granules prepared in the above item (1) for comparison.
was left in direct sunlight for 80 days.
保存後の各試料について、POVおよび生物学的活性物
質分解率を測定した。The POV and biologically active substance decomposition rate were measured for each sample after storage.
測定結果を、外観変化と共に第1表中に示す。The measurement results are shown in Table 1 along with changes in appearance.
第2表に示したように、本発明の反芻動物用飼料添加剤
においては、通常の作業場で貯蔵した場合においても変
質が認められず、冷暗所で保管した場合と同様に第1胃
対応液に対する生物学的活性物質の溶出率は極めて低(
、かつ第4胃対応液および小腸対応液で残部の大部分が
溶出する。As shown in Table 2, the ruminant feed additive of the present invention shows no deterioration even when stored in a normal workplace, and has the same effect on ruminal fluid as when stored in a cool dark place. The elution rate of biologically active substances is extremely low (
, and most of the remainder is eluted in the fluid corresponding to the abomasum and the small intestine.
これに対し、酸化チタン含有皮膜のみで被覆した製剤お
よび被覆のない製剤(比較例参照)においては、生物学
的活性物質の第1胃対応液に対する溶出率が大きい。On the other hand, in formulations coated only with a titanium oxide-containing film and formulations without coating (see Comparative Examples), the dissolution rate of biologically active substances in the ruminal fluid is high.
また酸化チタン皮膜を有しない保護皮膜のみの被覆製剤
においては、外観上でも変質が認められるだけでなく、
POVが著しく上昇し、また生物学的活性物質も分解し
ている。In addition, in coated preparations with only a protective film without a titanium oxide film, not only deterioration is observed in appearance, but also
POV increases significantly and biologically active substances are also degraded.
本発明の反芻動物用飼料添加剤は、前記実施例にも示し
たように、反芻動物に経口投与した場合に、それに含ま
れる生物学的活性物質の第1胃バイパス性か極めて優れ
るだけでなく、保存安定性も極めて優れている。As shown in the examples above, the feed additive for ruminants of the present invention not only has excellent ruminal bypass properties for biologically active substances contained therein when orally administered to ruminants. It also has excellent storage stability.
本発明は、経口投与した場合に反芻動物の第1胃で分解
されやすい生物学的活性物質を、第1胃をバイパスさせ
第4胃以降の消化器官で高効率で吸収させるに好適な、
保存安定性の優れた反芻動物用飼料添加剤を提供するも
のであり、その産業上、特に畜産分野における意義は極
めて大きい。The present invention provides biologically active substances that are easily degraded in the rumen of ruminants when administered orally, and which are suitable for bypassing the rumen and absorbing them with high efficiency in the digestive organs from the abomasum onwards.
The present invention provides a feed additive for ruminants with excellent storage stability, and has extremely great significance in industry, particularly in the livestock field.
Claims (6)
を、 (a)中性域では不溶性であり酸性域では分解性を示す
脂肪酸塩と、 (b)油脂およびワックスよりなる群から選ばれた少な
くとも1種とからなる保護皮膜と酸化チタン含有皮膜と
で二層被覆したことを特徴とする反芻動物用飼料添加剤(1) Core granules containing biologically active substances and protective substances are selected from the group consisting of (a) fatty acid salts that are insoluble in neutral ranges and degradable in acidic ranges, and (b) oils, fats, and waxes. A feed additive for ruminants characterized by being coated with two layers: a protective film consisting of at least one selected species and a film containing titanium oxide.
メチオニン、リシン塩酸塩およびビタミン類よりなる群
から選ばれた少なくとも1種である反芻動物用飼料添加
剤(2) A feed additive for ruminants according to claim (1), wherein the biologically active substance is at least one selected from the group consisting of methionine, lysine hydrochloride, and vitamins.
膜の成分である脂肪酸塩と同種の脂肪酸塩である反芻動
物用飼料添加剤(3) The feed additive for ruminants according to claim (1), wherein the protective substance is a fatty acid salt of the same type as the fatty acid salt that is a component of the protective film.
る脂肪酸塩が、融点40〜50℃の範囲にある混合脂肪
酸のカルシウム塩である反芻動物用飼料添加剤(4) The feed additive for ruminants according to claim (1), wherein the fatty acid salt as a component of the protective film is a calcium salt of mixed fatty acids having a melting point in the range of 40 to 50°C.
が、水溶性高分子皮膜に酸化チタンの粉末、フレーク等
を分散し含有させた皮膜である反芻動物用飼料添加剤(5) The feed additive for ruminants according to claim (1), wherein the titanium oxide-containing film is a water-soluble polymer film containing titanium oxide powder, flakes, etc. dispersed therein.
性セルロース誘導体である反芻動物用飼料添加剤(6) The feed additive for ruminants according to claim (4), wherein the water-soluble polymer is a water-soluble cellulose derivative.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2080807A JPH03280839A (en) | 1990-03-30 | 1990-03-30 | Feed additive for ruminant |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2080807A JPH03280839A (en) | 1990-03-30 | 1990-03-30 | Feed additive for ruminant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH03280839A true JPH03280839A (en) | 1991-12-11 |
Family
ID=13728742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2080807A Pending JPH03280839A (en) | 1990-03-30 | 1990-03-30 | Feed additive for ruminant |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH03280839A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0986313B1 (en) * | 1997-06-04 | 2006-09-06 | BASF Aktiengesellschaft | Starch-based phosphatase granulates |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS572435A (en) * | 1980-06-06 | 1982-01-07 | Japan Electronic Control Syst Co Ltd | Fuel injection controller |
| JPS63128437U (en) * | 1987-02-13 | 1988-08-23 | ||
| JPH0335445U (en) * | 1989-08-21 | 1991-04-08 |
-
1990
- 1990-03-30 JP JP2080807A patent/JPH03280839A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS572435A (en) * | 1980-06-06 | 1982-01-07 | Japan Electronic Control Syst Co Ltd | Fuel injection controller |
| JPS63128437U (en) * | 1987-02-13 | 1988-08-23 | ||
| JPH0335445U (en) * | 1989-08-21 | 1991-04-08 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0986313B1 (en) * | 1997-06-04 | 2006-09-06 | BASF Aktiengesellschaft | Starch-based phosphatase granulates |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005104868A1 (en) | Feed additive composition for ruminant, feed containing the same and process for producing feed additive composition for ruminant | |
| JP2879269B2 (en) | Ruminant granules | |
| JPS58175449A (en) | Feed additive composition for ruminant | |
| WO1991012731A1 (en) | Feed additive for ruminant | |
| JP7327383B2 (en) | Ruminant feed additive composition | |
| JPH03280841A (en) | Feed additive for ruminant | |
| JPH0545221B2 (en) | ||
| JP3266608B2 (en) | Ruminant feed additives | |
| JPS61195653A (en) | Particle for ruminant | |
| JPS63294747A (en) | Vitamin-containing feed additive for ruminant | |
| JPH03280839A (en) | Feed additive for ruminant | |
| JPH03280838A (en) | Feed additive for ruminant | |
| JPS6128351A (en) | Preparation of feed additive for ruminant | |
| JP2645497B2 (en) | Ruminant feed additives | |
| JPH03280837A (en) | Feed additive for ruminant | |
| JP2847879B2 (en) | Ruminant feed additives | |
| JPH0411848A (en) | Feed additive for ruminant | |
| JPS60168351A (en) | Feed additive composition | |
| JPH03254643A (en) | Feed additive for ruminant | |
| JP2533352B2 (en) | Feed additives for ruminants | |
| JPH03280836A (en) | Feed additive for ruminant | |
| JP2847880B2 (en) | Ruminant feed additives | |
| JP2847882B2 (en) | Ruminant feed additives | |
| JPH0411846A (en) | Feed additive for ruminant | |
| JPH03254642A (en) | Feed additive for ruminant |